轧后穿水冷却工艺对棒材组织性能的影响

针对轧机产量提高后冷床冷却能力不足的问题 ,研制开发了棒材轧后穿水冷却技术。通过对小规格 2 0MnSiV热轧带肋钢筋进行轧后穿水冷却 ,钢材上冷床温度降低了 90～ 110℃ ,提高了产品质量 ,改善了各项力学性能 ,抗拉强度平均提高了 3 5～ 40MPa ,钢材性能合格率由 97.5 %提高到了 99.6% ,解决了冷床冷却能力不足、制约生产的瓶颈问题。     

变频器的常见故障分析

本文阐述了变频器的常见故障，并针对常见故障提出了解决措施。     

聚丙烯增韧改性研究进展

综述了国内增韧改性聚丙烯的研究动向 ,介绍了近年来茂金属聚烯烃弹性体和有机/无机纳米粒子增韧聚丙烯的新技术     

二次电池电极基板用复合多孔金属材料的研究

介绍了一种复合金属多孔体的制备及其方法，首先以泡沫塑料为芯膜，经过导电化处理使其具有导电性，其次进行电沉积金属铁，再进行电沉积金属镍，经过热处理后可制备出复合金属多孔体。该复合金属多孔体用铁取代金属镍，其抗拉性能优于单质泡沫镍，同时可以降低制造成本，主要用于载体如电池电极。     

Bandwidth renegotiation for VBR video over ATM networks

A scheme for delivery or variable bit-rate (VBR) video over asynchronous transfer mode (ATM) networks where bandwidth can be renegotiated during the duration of a call between the video source and the network is considered. Renegotiation can be initiated by either the video source or the network. The video bandwidth requirement is characterized by a usage parameter control (UPC) consisting, in general, of peak rate, burst length, and sustained rate. A baseline design is outlined where rate-control adjusts the source's rate while a new UPC is requested from the network. When granted, the new UPC allows the source to maintain its target quantization and delay requirements. Rate control epochs may be extended when the network blocks UPC requests or sets a lower UPC value to temporally deal with congestion. Simulation results are presented for VBR MPEG video. The results show that with a moderate renegotiation rate the scheme tracks the bandwidth requirements of the source. As a result, the video quality and bandwidth efficiency can be maintained     

改善PZT微位移器线性的一种方法

根据锆钛酸铅压电陶瓷的逆压电效应。设计了以８０３１单片机为核心的压电陶瓷堆微位移器提高了ＰＺＴ的线性，从而满足了在天文自适应系统中所要求的精确微位的应用。     

Phenotypic analysis of antigen-specific T lymphocytes

Identification and characterization of antigen-specific T lymphocytes during the course of an immune response is tedious and indirect. To address this problem, the peptide-major histocompatability complex (MHC) ligand for a given population of T cells was multimerized to make soluble peptide-MHC tetramers. Tetramers of human lymphocyte antigen A2 that were complexed with two different human immunodeficiency virus (HIV)-derived peptides or with a peptide derived from influenza A matrix protein bound to peptide-specific cytotoxic T cells in vitro and to T cells from the blood of HIV-infected individuals. In general, tetramer binding correlated well with cytotoxicity assays. This approach should be useful in the analysis of T cells specific for infectious agents, tumors, and autoantigens.     

单液晶光阀彩色大屏幕投影显示

设计一电路,将彩色图象信息编码到黑白CRT的亮度之中,并将其写入液晶光阀,用白光读出,当编码合适时,读出的象颜色可与原图像一致。本文讨论了这一技术原理并进行了单液晶光阀彩色大屏幕投影的实验验证。     

Antibody- and cell-mediated immune responses of Actinobacillus pleuropneumoniae-infected and bacterin-vaccinated pigs

The number involved in and the rate of migration of donor leucocytes into the following recipient organs (spleen, thymus, bone marrow, lung and mesenteric lymph nodes) were measured in two rat models of orthotopic liver transplantation (OLT) using donor-specific MHC class I antibodies. The first OLT model is one that does not require immunosuppression in order to achieve tolerance and involved the transplantation of DA (MHC haplotype, RT1a) livers into PVG (RT1c) recipients. The second model was one that required a 7-day (10 mg/kg) treatment with cyclosporin A (CsA) to achieve tolerance and used DA donors into Lewis (RT1(1)) recipients. Recipient organs were biopsied on days 3, 20 and 87 following OLT and donor leucocyte migration was quantified by immunohistochemistry and computer densitometry of immunoblots of detergent-solublized tissues in order to resolve both membrane-bound and soluble donor MHC class I antigen. In a separate experiment, spleen biopsies were taken following OLT on days 3 and 15 from the naturally tolerizing OLT model (DA into PVG), treated with and without CsA for 7 days and compared with the (DA into Lewis) model. The initial rate of leucocyte migration between days 3 and 21 following OLT was found to be the most rapid into the spleen, followed by the bone marrow and mesenteric lymph nodes in the naturally tolerant (DA into PVG) model when compared with the (DA into Lewis) model. The number of donor leucocytes in the spleen and mesenteric lymph nodes in both models was, however, approximately the same by 87 days. No real difference in the rate of leucocyte migration was seen in the thymus or the lung for both transplant models over the time course assayed. CsA was found to lower the rate of donor leucocyte migration only over the period it was administered. The rate of donor leucocyte migration into the spleen was still much lower 15 days after OLT in the (DA into Lewis) model compared with the (DA into PVG) model treated with and without CsA. Thus the differences in the rate of donor leucocyte migration into the spleen, bone marrow and mesenteric lymph nodes immediately following OLT may offer an explanation as to why the (DA into PVG) combination is able to accept a transplanted liver without immunosuppressive therapy.